Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia.
This AFRAMED edition is in line with mobilizations for the success of 90-90-90 goals to put an end at the VIH epidemic from now until 2030. As principal access to treatments, AIDS screening tests are at the center of the scientific programs.
This symposium matches with the arrival of new antiviral molecules fort HVC. The “direct-acting antivirals” are more efficient, less toxic, with a limited treatment time and recovery rates higher than “bithérapies classiques”.
Tunisia will be a meeting space between technical partners, experts, epidemiologists and therapists.
Abstract submission deadline : June 30th 2017
You can submit your abstract here : https://reg.livebyglevents.com/AbstractSubmission/AFRAMED.aspx
For more informations : http://www.aframed2017.org/EventPortal/Information/AFRAMED/ACCUEIL.aspx
To consult the programme : http://www.aframed2017.org/EventPortal/Information/EventInformation.aspx?EventInformationPageCode=PROGRAMME2&EventCode=AFRAMED
To register : http://www.aframed2017.org/EventPortal/Information/EventInformation.aspx?EventInformationPageCode=INSCRIPTION&EventCode=AFRAMED